B cells expressing granzyme B have been postulated to possess antiviral and early tumor immunosurveillance functions, with granzyme B+ B cells exerting granzyme-mediated cytolytic activity against tumor cell lines in vitro (52–56). This evidence concerns the gene GZMB and neoplasm.